In addition to delivering excellence in teaching and clinical care, members of our Division are international leaders in microbial pathogenesis, immunology, and global and public health. Our investigators are recognized for their ground breaking discoveries from basic microbial pathogenesis and host defense to translational and clinical infectious disease research and implementation science. From model systems to human studies, we are making cutting edge discoveries and translating the latest knowledge into improvements in human health. We work in a highly collaborative environment that fosters rapid uptake of new technology and has a well-developed infrastructure that supports basic investigation and a pipeline to translational and clinical studies. Available resources include biosafety level 3 (BSL3) facilities and many outstanding core facilities, including those for genomics, imaging, genome engineering, and Cryo-EM. We attract top trainees and investigators, are highly successful competing for federal, foundation, and philanthropic funding, and seek to be transformative to human health. Read recent publications.

Research Support

The Division of Infectious Diseases was supported by more than $50 million in external funds in 2021. Sources of funding include:

Multidisciplinary training is supported by:

  • National Institutes of Health (NIH)
    • Research Grants, Career Development Awards, Program Project/Center Grants
    • T32 Infectious Disease/Basic Microbial Pathogenic Mechanisms Training Grant
    • K12 Multidisciplinary Clinical Research Career Development Program (MCRCDP)
  • Centers for Disease Control and Prevention (CDC)
  • Agency for Healthcare Research and Quality (AHRQ)

FY 2025 Grants

A listing of all current Infectious Diseases grants ≥ $300,000.

September
Principal InvestigatorSponsorGrant
Total Award
Diamond, MichaelScripps Research InstituteCenter For Antiviral Medicines & Pandemic Preparedness430,140
Diamond, MichaelNational Institute Of HealthMeningeal Immunity And Viral Neuropathogenesis384,256
Diamond, MichaelBavarian NordicCross-Neutralization Of Chikv Strains By Human Serum From Phase 3 Clinical Trial Of Ebsi-Cv-317-005335,312
Diamond, MichaelNational Institute Of HealthFlavivirus And Alphavirus Revampp33,122,681
Hseuh, KevinMissouri Department Of Health & Senior Services

Antimicrobial Stewardship Transformation Project999,472
August
Principal InvestigatorSponsorGrantAward Total
Diamond, MichaelNational Institute Of HealthHuman Antibody-Based Countermeasures Against The Wuhan Coronavirus Sars-Cov-2762,273
Diamond, MichaelVanderbilt University Medical CenterHuman Monoclonal Antibodies for Encephalitic Alpaviruses329,330
Philips, Jen National Institute Of HealthUnderstanding Early Macrophage-T Cell Interactions, Slamf1, And Immunity To Tb 772,420
July
Principal InvestigatorSponsorGrant
Award Total
Boon, JaccoNational Institute Of HealthTransmission Of CoV-2 And The Impact Of Spike Protein Evolution399,481
Diamond, MichaelNational Institute Of HealthLdlrad3 Receptor Interaction With Venezuelan Equine Encephalitis Virus388,307
Geng, Elvin HsingNational Institute Of HealthMidwest Developmental Center For AIDS Research (D-Cfar)412,348
Goldberg, Daniel E.National Institute Of HealthInfectious Disease/Basic Microbial Pathogenic Mechanisms337,583
Henderson, Jeffrey P.National Institute Of HealthMetabolomic Signatures Of Urologic Chronic Pelvic Pain Syndrome390,977
Kwon, Jennie H.Agency For Healthcare Research And QualityEnvironmental Hygiene Strategies To Decrease The Burden Of Antibiotic-Resistant Organisms In474,732
Kyei, George B.National Institute Of HealthProtein Interactions Regulating HIV Replication In Macrophages393,750
Leung, Daisy W.National Institute Of HealthMechanisms Of Host Response Modulation By RSV Non-Structural Proteins320,658

Explore the division’s clinical and basic research enterprises below and the faculty involved in each science category with their particular interests.